Maney PDF 101Kb

Exploring PIM1 as a measurable therapeutic target in early rheumatoid arthritis.

Nicola J Maney, Amy E Anderson, John D Isaacs, Arthur G Pratt

Institute of Cellular Medicine and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals & University